Grégoire Arnoux

Grégoire Arnoux

Auto-generated profile, based on publicly available information

Grégoire Arnoux

Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
GAGrégoire Arnoux
Grégoire Arnoux
DLDavid Legouis
David Legouis
MTMatthieu Tihy
Matthieu Tihy
RYRaphaël Yvon
Raphaël Yvon
NLNicolas Liaudet
Nicolas Liaudet
EFEric Feraille
Eric Feraille
Chronic kidney disease (CKD) is a growing public health crisis, affecting over 10% of the global population and significantly increasing mortality and morbidity. Irrespective of its underlying cause, tubulointerstitial fibrosis (TIF) is a hallmark of CKD progression, with myofibroblasts being the primary effectors of renal fibrosis. Here, we show that 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a critical driver of pathogenic myofibroblast differentiation and fibrosis in CKD. Using genetic deletion and pharmacological inhibition of 11β-HSD1 in mouse models, we demonstrate a marked reduction in TIF severity and improved renal function, linked to the suppression of a regulatory myofibroblast (Reg-MF) subpopulation. Single-cell and spatial transcriptomics data reveal that 11β-HSD1 is essential for the activation and expansion of Reg-MFs, which is conserved across species and predicts worse outcomes in CKD patients and kidney allograft recipients. These findings establish a direct link between 11β-HSD1 activity and renal fibrogenesis, highlighting its role during the transition from pericytes to pathogenic Reg-MFs. Our results support 11β-HSD1 inhibition as a promising therapeutic strategy to mitigate CKD progression, offering both mechanistic insights and translational potential for improving patient outcomes.

14 August 2026 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
CGCarl Guillaume Glessgen
Carl Guillaume Glessgen
AHAurélie Huber
Aurélie Huber
LCLindsey A. Crowe
Lindsey A. Crowe
SSSophie de Seigneux
Sophie de Seigneux
GAGrégoire Arnoux
Grégoire Arnoux
LBLena Berchtold
Lena Berchtold